ArticleBreast cancer research and treatment2008

NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.

Jiangbing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.